Introduction
Kawasaki disease (KD), also known as mucocuta neous lymph node syndrome, is an nCllte. self-limiting vasculitis th.at occurs in children of a11 ages, but pre dominantly when younger than 5 years. The syndrome was described for the first time by Tomisaku Kawasaki in 1967 1 . Although fever, rash, conjunctivitis, adenopathy, and geographic clustering suggest an infectious cause, no aetiologic agent has been identified yet 2 . KD is markedly more prevalent in East Asia. and the inci dence is reported to be highest in Japan and in chil dren of Japanese ancestry (174 per 100,000 children < 5 years)3,4. The annual incidence of KD is lower in children in Western countries, ranging from 17 to 18 per 100,000 (USA) to 8.4 per 100.000 (England)5.6 Today, KD has become the most prevalent acquired heart disease in children in developed countries.
ICle.CHltSC no specific diagnostic lest is available, the diagnosis of KD is mainly based on clinical findings related to all epidemiological case definition (table 1)1. Involvement of a CorOll<lry artery is the most s<;>wre complication of KD. and occurs in 15-25% of all untreated children. This may lead 10 myocardial hypo perfusion. ischaemic heart disease, myocardial infarc tion, or even sudden dealh 4 . Cardiovascular sequels also Lend to emerge later in life 7 Today, KD is diag nosed earlier, treated better. and a high number of patients reach adulthood 8 . Because the future perspectives of these patients are not yet well defined, we decided to determine mid term outcome by reviewing Ihe medical records of our KD patients. All patients, diagnosed with KD and in systematic follow-up at the department of paediatric or congen ital cardiology, were selected from the corresponding hospital database to be included in the study. Our data base contains the files of more than 30,000 patients with a congenital heart defect or patients who suffered from acquired heart disease in childhood. There were no exclusion criteria and the institutional ethics com mittee approved the study protocol.
REVIEW PROCESS
The medical records of the selected patients were reviewed. Patients' demographics and disease charac teristics were collected: gender, age at diagnosis. clini cal signs at diagnosis, laboratory findings at diagno sis. affected coronary artery, echocardiographic data (left ventricular function (normal was defined as ejec tion fraction more than or equal to 50'10), pericardial effusion, development of valvular disease or pul monary hypertension). immediate complications. and treatment regimen. The acute disease process was con sidered to be terminated when the inflammatory para meters normalized. Finally, mid-term follow-up data were obtained on reoccurrence of KD. arrhythmia, death. left ventricular function. and continued treat ment regimen.
STATISTICAL ANAL'YSrS
Continuous variables are reported as mean ± stan dard deviation (SD) . Median and range (minimum and maximum) are used when the data set is not normally distributed. Proportions are reported by percentages. Descriptive statistics are applied where applicable. The cumulative freedom from disease was calculated by a Kaplan-Meier analysis. Analysis was done by SPSS (version 16.0) for Windows.
Results
PArlF~ rs' CHARACTERISTICS Thirty-five patients were included in the analysis, 18 boys and 17 girls. The median age at diagnosis of KD was 1.9 years, ranging from 0.4 to 12.2 years. At the latest follow-up the mean age of the patients was 10.7 ± 5.4 years (range 2.0 -28.2 years). DISEASE CHARACTERISTICS, TREATME. 'T, AND SHORT TERM 0 TCOME The diagnostic criteria of our patient group and the corresponding laboratory lindings are summarized in table 2.
In 94(1;), and 5R' Yol of the cases, the left· od right coronary artery, respectively, was affected. In 54/(, both coronary arteries were involved in the disease process. The diagnosis of coronaritis was made by echocardio graphic evaluation (coronary artery aneurysm). Tn three patients, the left \cntricular ejection fraction worsened below 50~i;,. Pericardial effusion occurred in six patients, but was haemodynamicaUy not important. No patients developed significant valvular disease, but in 9 patients there was, temporarily, mild mitral valve regurgitation. No pulmonary hypertension occurred in the acute phase. All patients were treated with aspirin and thirty of them received sandoglobulin. In 10% of the patients, corticosteroids were added when the inflammation process persisted under aspirin and sandoglobulin ther apy (table 2) . In one patient, balloon dilatation was indicated because of progressive coronary artery steno sis and regional left ventricular hypokinesis. One patient needed inotropic support because of global heart failure.
The median duration of the active disease process was 0.5 months, ranging from 0.1 to 2.0 months. Cumu lative freedom from disease is plotted in figure 1 . 
MID-TERM FOLLOW-UP
The patients were followed up for a median of 4 years (range from 0.1 to 17.7 years). There was no disease recurrence, no significant arrhythmias occurred, and there were no deaths. In all patients the left ven tricular function remained normal, or nonnalized. In one patient, 10 years after the acute event, a coronary stent implantation was needed, because of myocardial ischaemia. Forty-three percent of our patien ts was still treated with a low dose of aspirin, but in none of the patients symptoms related to cardiac malfunctioning were present.
Discussion
Kawasaki disease is now known for over 40 years. As a result, there are more and more adult patients who suffered in childhood from KD. Still, late out come is not well defined yet. In this study we evaluated retrospectively the mid-term outcome of patients with a history of KD.
KD is a self-limiting vasculitis and the most severe complication of the disease process is coronaritis. In our population, almost all patients had echocardio graphic signs of coronaritis. In 94'10 and 58% of the cases, the left and right coronary artery, respectively, was affected. In 54% both coronary arteries were involved. This high prevalence might be related to a referral bias. Coronaritis usually leads to dilated coro nary arteries and aneurysms, that determine the echocardiographic diagnosis. The common sites of coronary aneurysms include, in order of highest to lowest risk, the proximal left anterior descend ens and proximal right coronary artery, followed by the left main coronary artery, then the left circuml1ex artery, and finally the distal right coronary artery and the junction between the right coronary artery and the posterior descending coronary artery'!. Although most of the coronary aneurysms will regress, the arterial vessel structure and function remain abnormal 9 . Some parts of the affected vessels remain unchanged, but might also become stenotic (with or without re-canal ization). In some very rare occasions, rupture of an aneurysm has occurred Not only the coronary arteries might be involved in the disease process. Pericardial effusion was found in 6 (17%) of our patients, and mitral valve regurgitation occurred in 9 patients; the noticed valve dysfunctions regressed completely. Valvular insufficiencies are mostly diagnosed in the acute disease process, and involve the mitral and in a lesser extent the aortic valve. The inci dence of valvular KD disease reported in literature (1-5%) is lower than the incidence we found in our group. Valve dysfunction is caused by valvulitis/pan carditis and tends to resolve spontaneously. Persistent valve regurgi tation is though t to be the result of myocardial ischaemic damage 4 ,13,14 and late-onset valve regurgitation has been related to progressive valve thickening and formation of fibrotic leaflets 13 ,ls. Fukunaga et a1. reported 2 cases in which aortic valve replacement was needed J6 .
The treatment of KD in the acute phase focuses on controlling inflammation and preventing thrombosis in the affected coronary arteries. The long-term treat ment is to avoid myocardial ischaemia or infarction due to persistent coronary artery lesions I4 ,l7,18. Aspirin is used for its anti-inl1ammatory and antiplatelet activ ity, but seems to have no effect on the development of coronary abnormalities l9 . In the acute phase it is administered in a high dose (80-100 mglkg daily), the dose is lowered afterwards, and, jf no coronary arter ies are damaged, stopped after normalization of inl1ammation markers l . The efficacy of gamma glob ulin infusion to reduce coronary artery abnormalities was proven during the late 1980 s, and, therefore, accepted as the mainstay therapy for KD, the latter in com bin ation with aspirin. A single dose of 2 g1kg gamma globulin infused over 10-12 hours is now the standard therapy in the USA, UK, Europe, Auslralia and several parts of Asia 1,10. All of our patients were treated with aspirin and intravenous gamma globulin, except one. Four of them (10%) were additionally treated with corticosteroids. The use of corticosteroids has been limited in children with KD 2 1. Studies per formed in the past showed no potential benefit, so the usefulnc~s of steroids in the initial treatment of KD is not yet clcar 4 . 14 ,22. However, when the coronary artery lesions lead to myocardial ischaemia, intervention is needed. Differ ent interventions have been performed on patients with com plica ted KD, incJ uding catheter interven tions, coronary artery bypass grafting (CASG), and even heart transplantation 23 . In 1976, Kitamura was the tirst to perform CASG in a patient with a coronary artery lesion due to KD 24 . He recently showed an excellent long-term survival after CASG (95% after 25 years), which was performed in patients as young as I year of age. But, on the other hand, in some series, the coronary artcry-related event-free rate seems to decline progres ivcly (60% after 25 years), which man dated continued follow-up25 In our series, the proxi mal right coronary artery was stented in one patient 10 years after the acute phase of KD. Stent implanta tion is preferable to balloon dilatation, especially in adults, because it may prevent new aneurysm forma tion and re-stenosis. In patients with severe calcified coronary artery stenosis, percutaneous transluminal coronary rotational ablation may be the only effective treatment. One study with 23 patients showed a good short-term outcome, but long-term outcome of catheter intervention in KD is still unclear20. 16-28 In 2001 . the research committee of the Japanese Ministry of Health. Labour, and Welfare, published guidelines for KD catheter intervenlions 27 .
Finally, we found that at the latest follow-up almost half of our patients were still treated with a low dose of aspirin, because there were still echocardiographical signs of coronary lesions. However, long-term prospec tive data with aspirin are lacking.
This study has some limitations. First, there might be a selection/referral bias; KD children suspected with involvement of the heart were probably preferentially referred to the paediatric cardiologist. Second, it is a single-centre study, therefore extrapolation of our data needs careful interpretation. Third, this is a retrospec tive study. hence data could only be obtained by reviewing the patients' files.
Summary
The mid-term outcome of patients who suffered in childhood from Kawasaki disease is excellent. How ever, almost half of them were treated with oral aspirin during follow-up.
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